| abstract |
The present disclosure relates generally to cross-linked cationically bound polymers comprising monomers containing carboxylic acid groups, wherein the polymer is calcium that is a counter ion for about 15% to about 35% of the carboxylic acid groups in the polymer. And / or contains magnesium cations. The present disclosure also provides methods for preparing the polymers, compositions, formulations, and dosage forms containing the polymers, and for treating various diseases or disorders, including those involving ionic and / or fluid imbalances. It also relates to the use of the polymer, composition, formulation and / or dosage form. |